Biotech
Vadim Gladyshev and the Science of Aging
Publication: Ground Truths
Author: Eric Topol
Source published: 27/10/2026, 00:00:39 UTC
Briefing created: 27/10/2026, 01:10:25 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 27/10/2026, 00:12:23 UTC.
Briefings
Vadim Gladyshev, a PhD professor at Brigham and Women's Hospital and elected to the National Academy of Science, is a prominent researcher in the science of aging. The article outlines his work on biological aging clocks, including proteomic, transcriptomic, and metabolomic clocks, alongside emerging wearable technologies like facial and voice clocks. It also discusses his research on transplanting hearts between young and old donors and the effects of semaglutide on aging, noting that these topics are presented as preprints or ongoing studies. The text highlights Ground Truths' subscriber base and its role in funding a record number of summer interns in 2026, but does not provide specific data on the clinical impact of his research or the outcomes of his specific studies.
Key points
- Vadim Gladyshev is a PhD professor at Brigham and Women's Hospital and a member of the National Academy of Science.
- Gladyshev's research focuses on biological aging clocks, including proteomic, transcriptomic, and metabolomic clocks, as well as wearable technologies like facial and voice clocks.
Context
Vadim Gladyshev is a leading researcher in the science of aging, with credentials including a PhD and election to the National Academy of Science. His work explores various aging mechanisms and biomarkers, including proteomic and transcriptomic clocks, and discusses emerging wearable technologies for monitoring aging. The article also touches on his research into heart transplantation between young and old donors and the effects of semaglutide on aging, though specific study outcomes are not detailed.
Limitations
The provided evidence is limited to a list of topics covered in the article, including specific types of aging clocks and research areas like heart transplantation and semaglutide effects. It does not contain specific dates, numbers, or outcomes from Gladyshev's studies, nor does it provide details on the clinical impact of his research or the results of his specific experiments.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 27/10/2026, 01:10:25 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeihgjuo3x356ztvxexi7fkieuuovw333inc2l7t3lwm3rdfnnvuw7m